Cell Freezing Media for Cell Therapy Market

Cell freezing medium is a complete cell freezing media for mammalian cell cultures.

Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.

Cell Freezing Media for Cell Therapy Market contains market size and forecasts of Cell Freezing Media for Cell Therapy in global, including the following market information:

Global Cell Freezing Media for Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cell Freezing Media for Cell Therapy Market Sales, 2017-2022, 2023-2028, (Liters)

Global top five Cell Freezing Media for Cell Therapy companies in 2021 (%)

The global Cell Freezing Media for Cell Therapy market was valued at 69 million in 2021 and is projected to reach US$ 158.5 million by 2028, at a CAGR of 12.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

With FBS Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell Freezing Media for Cell Therapy include BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare and Zenoaq, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cell Freezing Media for Cell Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell Freezing Media for Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Liters)

Global Cell Freezing Media for Cell Therapy Market Segment Percentages, by Type, 2021 (%)

With FBS

Without FBS

Global Cell Freezing Media for Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Liters)

Global Cell Freezing Media for Cell Therapy Market Segment Percentages, by Application, 2021 (%)

Human Embryonic Stem Cells

CAR-T Cell Therapy

Neural Stem Cell Therapy

Mesenchymal Stem Cell Therapy

Hematopoietic Stem Cell Transplantation

Others

Global Cell Freezing Media for Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Liters)

Global Cell Freezing Media for Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell Freezing Media for Cell Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cell Freezing Media for Cell Therapy revenues share in global market, 2021 (%)

Key companies Cell Freezing Media for Cell Therapy sales in global market, 2017-2022 (Estimated), (Liters)

Key companies Cell Freezing Media for Cell Therapy sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

BioLife Solutions

Thermo Fisher Scientific

Merck

GE Healthcare

Zenoaq